➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Last Updated: July 27, 2021

DrugPatentWatch Database Preview

Details for Patent: 7,420,057

Email this page to a colleague

« Back to Dashboard

Which drugs does patent 7,420,057 protect, and when does it expire?

Patent 7,420,057 protects ADDYI and is included in one NDA.

This patent has forty patent family members in thirty countries.

Summary for Patent: 7,420,057

Title:	Stable polymorph of flibanserin
Abstract:	The invention relates to the polymorph A of flibanserin, to a technical process for the preparation thereof, as well as to the use thereof for preparing medicaments.
Inventor(s):	Bombarda; Carlo (Chester, VA), Dubini; Enrica (Milan, IT), Ezhaya; Antoine (Milan, IT), Schneider, legal representative; Margarete (Ingelheim, DE), Schneider; Heinrich (Ingelheim, DE)
Assignee:	Boehringer Ingelheim Pharma KG (Ingelheim, DE)
Application Number:	11/546,304
Patent Claim Types: see list of patent claims	Compound; Composition; Process;

Drugs Protected by US Patent 7,420,057

Subscribe to access the full database, or Try it Free
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Sprout Pharms	ADDYI	flibanserin	TABLET;ORAL	022526-001	Aug 18, 2015		RX	Yes	Yes	⤷ Try it Free	⤷ Try it Free	Y	Y			⤷ Try it Free
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Patented / Exclusive Use	>Submissiondate

Foreign Priority and PCT Information for Patent: 7,420,057

Foriegn Application Priority Data
Foreign Country	Foreign Patent Number	Foreign Patent Date
	01118593	Aug 2, 2001
	01130180	Dec 19, 2001

International Family Members for US Patent 7,420,057

Subscribe to access the full database, or Try it Free
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Argentina	036208	⤷ Try it Free
Argentina	077416	⤷ Try it Free
Austria	288911	⤷ Try it Free
Australia	2002331361	⤷ Try it Free
Brazil	0211601	⤷ Try it Free
Brazil	122012029907	⤷ Try it Free
Canada	2450093	⤷ Try it Free
>Country	>Patent Number	>Estimated Expiration	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys

Baxter

Colorcon

McKinsey

McKesson

Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.